An effect comparison of perioperative intravenous metoprolol bolus in 137 cases and intravenous calcium iron antagonist injection in 128 cases with noncardiac surgery

Luo Xin-ping,NI Huan-chun,Shan Ying,SHI Hai-ming,Li Jian,ZHU Jun,Li Yong,FAN Wei-hu
DOI: https://doi.org/10.3969/j.issn.1673-6583.2009.02.017
2009-01-01
Abstract:Objective:To compare the efficacy and tolerance of perioperative intravenous metoprolol or calcium iron antagonist injection on patients with cardiac complications which undergoing noncardiac surgery. Methods:The clinical data of 265 patients who underwent noncardiac surgery from March 2003 to May 2007 was analyzed. According to the different drugs used to treat the perioperative cardiac complications (tachycardia arrhythmia and hypertension),patients were allocated to metoprolol group (137 cases)and calcium antagonist group (128 cases,including verapamil 51 patients and diltiazem 77 patients).The effects of the therapy on heart rate and blood pressure control and were compared between two groups. Results:There is no significant difference at baseline data between two groups. Compared with calcium antagonist,intravenous metoprolol could more reduce heart and quickly. The effect of blood pressure controlling was more significant in calcium antagonist group than in metoprolol group. The incidence of side-effects events was lower in metoprolol (10.9%) than that in calcium antagonist group (23.4%). Conclusion:Intravenous metoprolol injection is effective and safe in treating perioperative cardiac complications in patients with noncardiac surgery.
What problem does this paper attempt to address?